Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Freeman, Cope to answer MP questions on Team Sky probe

Published 31/01/2017, 07:41
Updated 31/01/2017, 07:41
© Reuters. Team Sky rider Wiggins cycles with BMC Racing Team rider Evans during the seventh stage of the 99th Tour de France cycling race between Tomblaine and La Planche des Belles Filles

(Reuters) - Former Team Sky doctor Richard Freeman and Simon Cope, who delivered a medical package to cyclist Bradley Wiggins at the 2011 Criterium du Dauphine, will be questioned by MPs next month over allegations of wrongdoing.

Former coach Shane Sutton told MPs last month that the package had contained medicine that was administered to the British 2012 Tour de France winner by Freeman.

Cope, a former British Cycling employee who denies any misconduct, said he had not yet been officially summoned by the Culture, Media and Sport select committee, which will also question UK Anti-Doping (UKAD) head Nicole Sapstead on Feb. 22.

"I want to clear it up because I'm fed up with my name being dragged through the mud," Cope told British media. "To this day, hand on heart, on my kids' hearts, I do not know what was in there. I was asked to do a job.

"I was told by senior management, 'We want you to do that' or, "Do this'... People say, 'You're naive, you should have asked because you're going through customs'. Maybe I was, but also why would I question?

"I had been working at British Cycling for eight years and I had never seen anything to question."

Cycling has been rocked by revelations that a mysterious jiffy bag containing medication was transported to France by British Cycling women's team manager Cope for Wiggins and Team Sky at the 2011 race.

Team Sky's use of Therapeutic Use Exemptions (TUEs) has also been under investigation after cyber-hacking website Fancy Bears leaked medical information held by the World Anti-Doping Agency (WADA) on Wiggins and former team mate Chris Froome.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Neither rider is suspected of any wrongdoing.

Team Sky boss Dave Brailsford has also already given evidence to the select committee, saying in December that the "mystery" delivery reported in a Daily Mail story was WADA-approved decongestant Fluimucil.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.